AXTX: Tradr 2X Long AXTI Daily ETF Gains +15% in 30 Days but Declines -77% Over the Quarter

Key Takeaways

• AXTX gained approximately 15% over the past 30 days, recovering from extreme lows as underlying stock AXTI rallied on transformative corporate developments.
• Over the last quarter, AXTX has declined roughly 77%, illustrating the severe compounding and volatility decay effects inherent to daily-reset leveraged exchange-traded funds (ETFs).
• The primary catalyst was AXT, Inc.'s record Q2 2026 earnings, which featured revenue of $47.6 million (+164% year-over-year) and a definitive return to profitability, alongside multiple long-term indium phosphide supply agreements.
• As a 2x leveraged single-stock ETF with a 1.49% expense ratio, AXTX is designed exclusively for short-term tactical trading and magnifies both daily gains and losses in the underlying security.
• AI-driven demand for indium phosphide substrates used in data center optical connectivity remains the dominant investment theme, with AXTI's backlog exceeding $100 million.

Understanding the Tradr 2X Long AXTI Daily ETF (AXTX) and Its Exposure

The Tradr 2X Long AXTI Daily ETF seeks daily investment results, before fees and expenses, that correspond to 200% of the daily performance of the common shares of AXT, Inc. (AXTI). Launched on April 24, 2026 and managed by AXS Investments LLC under the Tradr ETFs brand, the fund is actively managed and maintains at least 80% exposure to financial instruments — primarily swaps and derivatives — that provide two times leveraged exposure to AXTI. It carries a net expense ratio of 1.49% and is structured as a non-diversified fund. I also checked comparable leveraged products using Tickeron’s AI Screener to see how AXTX fits within the broader industry landscape.

AXT, Inc. is a materials science company that designs, develops, and manufactures high-performance compound and single-element semiconductor substrate wafers, including indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge). The company supplies substrates used in 5G infrastructure, data center silicon photonics, passive optical networks, lasers, sensors, and satellite solar cells. Its manufacturing operations are primarily located in China, with headquarters in Fremont, California. This concentrated single-stock exposure — amplified by 2x daily leverage — makes AXTX one of the most volatile ETFs available, entirely dependent on AXTI's share price trajectory.

AXTX Price Performance: 30-Day Rebound Versus Quarterly Drawdown

Over the last 30 days, AXTX rose from a closing price of $9.60 on July 8, 2026, to $11.01 on August 6, 2026 — a gain of approximately 15%. This advance was neither linear nor orderly. The ETF continued to slide through mid-July, bottoming at $3.01 on July 29, before a powerful multi-session reversal propelled it back into the double digits. The rally was compressed into a handful of trading sessions following AXTI's late-July catalyst cluster.

The quarterly picture tells a starkly different story. From a closing price of $48.42 on May 7, 2026, AXTX has declined roughly 77% to its current level. The fund reached an all-time high of $73.02 on May 22 before a punishing multi-month drawdown erased the overwhelming majority of its value. This divergence between the 30-day bounce and the quarterly collapse highlights the path-dependent nature of daily-reset leveraged products: even when the underlying stock stages a sharp recovery, the mathematical compounding of daily returns during periods of high volatility can permanently impair fund NAV (Net Asset Value) for holders who remain invested beyond a single trading session.

Key Drivers Behind AXTX’s 30-Day Move

The last 30 days were defined by a dramatic pivot in AXTI's fundamental narrative. The single most consequential event was AXT, Inc.'s Q2 2026 earnings release on July 30, which dramatically exceeded consensus expectations. The company reported record quarterly revenue of $47.6 million, up 164% year-over-year, and non-GAAP earnings per share (EPS) of $0.19 — surpassing the $0.07 consensus estimate by over 170%. Non-GAAP gross margin expanded to 45.0%, up from 29.9% in the prior quarter. Indium phosphide revenue alone reached a record $30.7 million, cementing InP as the company's primary growth engine.

Just one day earlier, on July 29, AXT announced a definitive long-term supply and capacity reservation agreement with LITE (Lumentum Operations), under which Lumentum committed to $87 million in deposits applied as shipment credits through 2031. This followed earlier agreements with COHR (Coherent) and Casela, together representing over $130 million in customer prepayments. These agreements validated the thesis that AI data center demand for indium phosphide substrates — the critical material in high-speed optical transceivers — is structural rather than cyclical. Needham & Company upgraded AXTI to Buy with a $90 price target on July 31, further reinforcing positive sentiment. AXTI shares, which had fallen as low as $36.97 on July 29, surged to $75.17 by August 6, and AXTX — amplified by 2x leverage — followed sharply higher.

Factors Behind the Quarterly Performance Decline

The broader three-month trend was dominated by a severe and prolonged sell-off that wiped out more than three-quarters of the ETF's value. AXTI entered May 2026 trading above $100 per share, propelled by extraordinary year-to-date gains exceeding 650% as investors priced in the AI-driven indium phosphide growth story. However, multiple headwinds converged to trigger a brutal reversal. A short report from J Capital Research alleged that Chinese regulators had blocked the IPO of AXTI's Tongmei subsidiary, accusing the company of tax evasion and questioning the authenticity of its AI-linked demand narrative. Insider selling intensified, with over $43 million in AXTI shares sold by company executives and directors during the quarter.

Valuation concerns also weighed heavily. At its May peak near $143, AXTI traded at a trailing price-to-earnings (P/E) ratio exceeding 400x, with independent fair-value models suggesting the stock was thousands of percent overvalued relative to historical fundamentals. A proposed increase in authorized shares from 70 million to 120 million — intended to fund indium phosphide capacity expansion — sparked dilution fears. The combination of these factors drove AXTI down more than 70% from peak to trough, and AXTX, with its 2x daily multiplier subject to volatility decay, suffered a far deeper drawdown of approximately 95% from its May high.

AXTX ETF Outlook: Factors to Monitor

The trajectory of AXTX will remain inextricably linked to AXTI's share price and the durability of the AI-driven indium phosphide demand narrative. Several factors merit close attention in the months ahead. First, AXTI's Q3 2026 execution against its guidance of approximately $66 million in revenue and non-GAAP EPS of $0.30–$0.32 will test whether the Q2 inflection was a one-time event or the beginning of a sustained earnings cycle. Second, export permit dynamics remain a persistent risk: AXTI's Chinese manufacturing base means that U.S. export controls and regulatory friction could disrupt revenue recognition and capacity expansion timelines. Third, the company's plan to triple indium phosphide capacity by end-2027 — targeting approximately $130 million in quarterly capacity — will require flawless operational execution and sustained customer demand.

From a structural perspective, investors should recognize that AXTX is not designed for multi-day holding periods. The mathematical effects of daily reset and compounding mean that even if AXTI shares appreciate over time, AXTX may significantly underperform or lose value during periods of elevated volatility. The ETF's 1.49% expense ratio further compounds the cost of holding the fund beyond very short time horizons. For those monitoring the broader semiconductor substrate industry, the supply-demand imbalance in indium phosphide — where global demand is estimated at roughly 260–300 million wafer equivalents against effective capacity of approximately 75 million — suggests that pricing power and backlog growth could persist, though geopolitical disruption, competitive capacity additions, and shifts in AI capital expenditure trends represent material risks to the thesis.

Using Tickeron’s AI Screener in My Analysis

In reviewing leveraged ETFs like AXTX, I frequently rely on Tickeron’s AI Screener to scan for comparable instruments and emerging patterns across the sector. This AI-powered platform lets me apply technical indicators, volatility filters, and performance metrics to quickly surface relevant opportunities that align with a short-term trading approach. It has proven especially useful when evaluating high-volatility products tied to single-stock themes. Explore the AI Screener for your own data-driven screening needs.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Contributor

Jimmy Landsman|Expert

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.

Industry description